Latest Management of obesity Stories
Study Released as part of Obesity Journal Symposium at Obesity Week(SM) 2014 BOSTON, Nov.
New research adds evidence that distraction techniques may improve weight loss BOSTON, Nov.
Results validate ReShape(TM) Procedure as a potential new treatment option for patients with a BMI of 30-40, for whom surgery is not an option and diet and exercise alone have failed BOSTON
ObesityWeek 2014 Conference Features New Research on Achieving Clinically Significant Weight Loss BOSTON, Nov.
Of those, 83% should be considered for pharmacotherapy, 23% could be candidates for bariatric surgery BOSTON, Nov.
-- Results of Investigational Study of Coadministration of Lorcaserin and Phentermine Accepted as Late Breaking Poster -- WOODCLIFF LAKE, N.J. and SAN DIEGO, Oct.
DUBLIN, October 30, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/gc2mn9/global_bariatric) has announced the addition of the "Global
EnteroMedics to Host Third Quarter 2014 Financial Results Conference Call on November 12, 2014 at 11:00 AM ET ST. PAUL, Minn., Oct. 30, 2014 /PRNewswire/ -- EnteroMedics Inc.
Health experts have been warning for years that crash weight-loss diets, often arriving in the form of a fad diet, do not lead to permanent weight loss and can in fact cause a person to regain weight faster than if they would have with a ‘slow and steady’ weight loss diet.
LONDON, Oct. 16, 2014 /PRNewswire/ -- This report analyzes the worldwide markets for Anti-Obesity Drugs in US$ Million.